This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chengdu Baiyu Ginkgolide Pharmaceuticals Co. Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Hong Ke
Introduction
Hong Ke is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceuticals, particularly with his work on Ginkgolide B derivatives. His innovative approach has led to the development of a unique compound that holds promise for various applications.
Latest Patents
Hong Ke holds 1 patent for his invention titled "Ginkgolide B derivative and preparation method and use thereof." This patent discloses a compound represented by specific formulas, which includes a pharmaceutically acceptable salt. The compound features a selection of pyrazinyl or substituted pyrazinyl groups, as well as phenyl or substituted phenyl, and alkyl or substituted alkyl groups.
Career Highlights
Hong Ke is associated with Chengdu Baiyu Ginkgolide Pharmaceuticals Co. Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also enhanced the understanding of Ginkgolide compounds.
Collaborations
Hong Ke has collaborated with notable colleagues, including Daxiong Li and Huiqin Li. Their combined expertise has fostered a productive research environment, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Hong Ke's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile